Table 3.

Association of blood lactate quartiles with the prevalence of MAFLD.

	ORs (95% CI)				p values for trend
	Q1	Q2	Q3	Q4
Model 1	1	1.412 (1.185-1.683)	1.896 (1.596-2.251)	2.973 (2.503-3.530)	<0.001
Model 2	1	1.475 (1.232-1.765)	1.989 (1.668-2.373)	3.052 (2.556-3.645)	<0.001
Model 3	1	1.455 (1.201-1.764)	1.828 (1.514-2.208)	2.966 (2.453-3.586)	<0.001
Model 4	1	1.391 (1.146-1.688)	1.713 (1.415-2.073)	2.643 (2.179-3.205)	<0.001
Model 5	1	1.444 (1.140-1.829)	1.614 (1.275-2.043)	2.683 (2.105-3.421)	<0.001
Model 6	1	1.436 (1.102-1.870)	1.473 (1.129-1.922)	2.055 (1.563-2.702)	<0.001

Model 1: unadjusted.

Model 2: Adjusted for age, sex, and DD.

Model 3: Further adjustment for obesity, smoking status, and alcohol drinking.

Model 4: Further adjustment for use of LLD, IIAs, and insulin sensitizers.

Model 5: Further adjustment for WC, WHR, and BMI.

Model 6: Further adjustment for TC, HDL-C, LDL-C, TG, eGFR, SUA, UAE, FPG, 2-h PPG, HbA1c, CRP, FCP, and 2-h PCP.